Incidence and determinants of initiation into cocaine injection and correlates of frequent cocaine injectors

Drug and Alcohol Dependence

Volumn 99, Issue 1-3, 2009, Pages 176-182

  Lloyd Smith, Elisa ^a,b   Wood, Evan ^a,b   Li, Kathy ^a   Montaner, Julio S G ^a,b   Kerr, Thomas ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cocaine; HIV; Injection drug use; Risk factors

Indexed keywords

COCAINE; DIAMORPHINE;

ADULT; ARTICLE; COCAINE DEPENDENCE; COHORT ANALYSIS; FEMALE; FOLLOW UP; HEROIN DEPENDENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SYRINGE;

ADULT; BRITISH COLUMBIA; COCAINE-RELATED DISORDERS; COHORT STUDIES; ETHNIC GROUPS; FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; NEEDLE SHARING; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTITUTION; SEX FACTORS; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 57049178362     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2008.07.003     Document Type: Article

References (37)

1. Bux D.A., Lamb R.J., and Iguchi M.Y. Cocaine use and HIV risk behavior in methadone maintenance patients. Drug Alcohol Depend. 37 (1995) 29-35
2. Chaisson R.E., Bacchetti P., Osmond D., Brodie B., Sande M.A., and Moss A.R. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA 261 (1989) 561-565
3. Corneil T.A., Kuyper L.M., Shoveller J., Hogg R.S., Li K., Spittal P., Schechter M.T., and Wood E. Unstable housing, associated risk behaviour, and increased risk for HIV infection among injection drug users. Health Place 12 (2006) 79-85
4. Darke S., Kaye S., and Ross J. Geographical injecting locations among injecting drug users in Sydney, Australia. Addiction 96 (2001) 241-246
5. Degenhardt L., Day C., Hall W., Conroy E., and Gilmour S. Was an increase in cocaine use among injecting drug users in New South Wales, Australia, accompanied by an increase in violent crime?. BMC Public Health 5 (2005)
6. de Lima M.S., de Oliveira Soares B.G., Reisser A.A., and Farrell M. Pharmacological treatment of cocaine dependence: a systematic review. Addiction 97 (2002) 931-949
7. Diggle P.J., Liang K., and Zeger S. Analysis of Longitudinal Data (1996), Oxford University Press, New York
8. Durante A.J., Hart G.J., Brady A.R., Madden P.B., and Noone A. The Health of the Nation target on syringe sharing: a role for routine surveillance in assessing progress and targeting interventions. Addiction 90 (1995) 1389-1396
9. Epstein D.H., Hawkins W.E., Covi L., Umbricht A., and Preston K.L. Cognitive-behavioral therapy plus contingency management for cocaine use: findings during treatment and across 12-month follow-up. Psychol. Addict. Behav. 17 (2003) 73-82
10. Galea S., Nandi A., Coffin P.O., Tracy M., Markham Piper T., Ompad D., and Vlahov D. Heroin and cocaine dependence and the risk of accidental non-fatal drug overdose. J. Addict. Dis. 25 (2006) 79-87
11. Greenfield L., Bigelow G.E., and Brooner R.K. Validity of intravenous drug abusers' self-reported changes in HIV high-risk drug use behaviors. Drug Alcohol Depend. 39 (1995) 91-98
12. Hudgins R., McCusker J., and Stoddard A. Cocaine use and risky injection and sexual behaviors. Drug Alcohol Depend. 37 (1995) 7-14
13. Kaye S., and Darke S. Injecting and non-injecting cocaine use in Sydney, Australia: physical and psychological morbidity. Drug Alcohol Rev. 23 (2004) 391-398
14. Kerr T., Tyndall M., Li K., Montaner J., and Wood E. Safer injection facility use and syringe sharing in injection drug users. Lancet 366 (2005) 316-318
15. Kral A.H., Bluthenthal R.N., Booth R.E., and Watters J.K. HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities. Am. J. Public Health 88 (1998) 108-113
16. Kral A.H., Bluthenthal R.N., Erringer E.A., Lorvick J., and Edlin B.R. Risk factors among IDUs who give injections to or receive injections from other drug users. Addiction 94 (1999) 675-683
17. Kral A.H., Lorvick J., and Edlin B.R. Sex- and drug-related risk among populations of younger and older injection drug users in adjacent neighborhoods in San Francisco. J. Acquir. Immune Defic. Syndr. 24 (2000) 162-167
18. Latkin C.A., Vlahov D., and Anthony J.C. Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction 88 (1993) 517-526
19. Maher L., Jalaludin B., Chant K.G., Jayasuriya R., Sladden T., Kaldor J.M., and Sargent P.L. Incidence and risk factors for hepatitis C seroconversion in injection drug use in Australia. Addiction 101 (2006) 1449-1508
20. Miller C.L., Kerr T., Frankish J.C., Spittal P.M., Li K., Schechter M.T., and Wood E. Binge drug use independently predicts HIV seroconversion among injection drug users: implications for public health strategies. Subst. Use Misuse 41 (2006) 199-210
21. Patterson T.L., Semple S., Fraga S.J., Bucardo J., Davilla-Fraga W., and Strathdee S.A. An HIV-prevention intervention for sex workers in Tijuana, Mexico: a pilot study. Hisp. J. Behav. Sci. 27 (2005) 82-100
22. Rhodes T. The 'risk environment': a framework for understanding and reducing drug-related harm. Int. J. Drug Policy 13 (2002) 85-94
23. Rhodes T., Kimber J., Small W., Fitzgerald J., Kerr T., Hickman M., and Holloway G. Public injecting and the need for 'safer environment interventions' in the reduction of drug-related harm. Addiction 101 (2006) 1384-1393
24. Shearer J., and Gowing L.R. Pharmacotherapies for problematic psychostimulant use: a review of current research. Drug Alcohol Rev. 23 (2004) 203-211
25. Shearer J., Wodak A., Van Beek I., Mattick R.P., and Lewis J. Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence. Addiction 98 (2003) 1137-1141
26. Spittal P.M., Craib K.J., Wood E., Laliberte N., Li K., Tyndall M.W., O'Shaughnessy M.V., and Schechter M.T. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. CMAJ 166 (2002) 894-899
27. Topp L., Day C., and Degenhardt L. Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia. Drug Alcohol Depend 70 (2003) 275-286
28. Tyndall M.W., Patrick D., Spittal P., Li K., O'Shaughnessy M.V., and Schechter M.T. Risky sexual behaviours among injection drugs users with high HIV prevalence: implications for STD control. Sex Transm. Infect. 78 Suppl 1 (2002) i170-i175
29. Tyndall M.W., Currie S., Spittal P., Li K., Wood E., O'Shaughnessy M.V., and Schechter M.T. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS 17 (2003) 887-893
30. Tyndall M., Kerr T., Zhang R., King E., Montaner J.G., and Wood E. Attendance, drug use patterns, and referrals made from North America's first supervised injection facility. Drug Alcohol Depend. 83 (2005) 193-198
31. Tyndall M.W., Wood E., Zhang R., Lai C., Montaner J.S., and Kerr T. HIV seroprevalence among participants at a Supervised Injection Facility in Vancouver, Canada: implications for prevention, care and treatment. Harm. Reduct. J. (2006) 3
32. Wood E., Tyndall M.W., Spittal P.M., Li K., Hogg R.S., Montaner J.S., O'Shaughnessy M.V., and Schechter M.T. Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. AIDS 16 (2002) 941-943
33. Wood E., Spittal P.M., Kerr T., Small W., Tyndall M.W., O'Shaughnessy M.V., and Schechter M.T. Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: Implications for HIV prevention. Can. J. Public Health 94 (2003) 355-359
34. Wood E., Kerr T., Montaner J.S., Strathdee S.A., Wodak A., Hankins C.A., Schechter M.T., and Tyndall M.W. Rationale for evaluating North America's first medically supervised safer-injecting facility. Lancet Infect. Dis. 4 (2004) 301-306
35. Wood E., Kerr T., Li K., Small W., Miller C., Tyndall M., and Schechter M. Recent incarceration independently predicts syringe sharing among injection drug users. Public Health Rep. 120 (2005) 150-156
36. Wood E., Tyndall M., Li K., Lloyd-Smith E., Small W., Montaner J., and Kerr T. Do supervised injecting facilities attract higher-risk injection drug users?. Am. J. Prev. Med. 29 (2005) 126-130
37. Wood E., Schachar J., Li K., Stoltz A., Shannon K., Miller C., Lloyd-Smith E., Tyndall M.W., and Kerr T. Sex trade involvement is associated with elevated HIV incidence among injection drug users in Vancouver. Addict. Res. Theor. 15 (2007) 321-325